Medical Devices - APAC

  • APAC
  • The projected revenue in the Medical Devices market market in the Asia-Pacific (in Asia-Pacific) region is expected to reach US$103.10bn in 2024.
  • Among the various markets within the market, Cardiology_Devices is anticipated to be the largest, with a projected market volume of US$14.62bn in 2024.
  • Looking ahead, the market is expected to witness an annual growth rate (CAGR 2024-2029) of 7.29%, leading to a market volume of US$146.60bn by 2029.
  • It is worth noting that in a global context, the United States is projected to generate the highest revenue, amounting to US$179.80bn in 2024.
  • In Japan, the medical device market is dominated by domestic manufacturers, with a strong emphasis on technological innovation and quality.

Key regions: Germany, Spain, Japan, United Kingdom, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Devices market in APAC is experiencing significant growth and development, driven by various factors such as increasing healthcare expenditure, growing aging population, and advancements in technology. Customer preferences in the Medical Devices market in APAC are influenced by several factors. Firstly, customers in this region prioritize quality and reliability when it comes to medical devices. They are willing to pay a premium for products that are known for their effectiveness and durability. Additionally, customers in APAC also value affordability, as healthcare costs can be a burden for many individuals in the region. Therefore, medical devices that offer a balance between quality and affordability are in high demand. Trends in the Medical Devices market in APAC are shaped by the unique characteristics of each country in the region. For example, in countries with rapidly aging populations like Japan and South Korea, there is a growing demand for medical devices that cater to the needs of elderly individuals. This includes devices such as mobility aids, home healthcare equipment, and monitoring devices. On the other hand, in countries with emerging economies like India and China, there is a rising demand for basic medical devices that can provide essential healthcare services to a large population. This includes devices such as diagnostic equipment, surgical instruments, and basic healthcare supplies. Local special circumstances also play a role in the development of the Medical Devices market in APAC. For instance, in countries with universal healthcare systems like Australia and Singapore, the government plays a significant role in regulating and funding the purchase of medical devices. This creates a unique market environment where government policies and reimbursement schemes heavily influence customer preferences and market dynamics. Additionally, cultural factors also impact the adoption of medical devices in APAC. Traditional medicine practices are still prevalent in many countries, and this can influence the acceptance and usage of modern medical devices. Underlying macroeconomic factors also contribute to the growth of the Medical Devices market in APAC. For example, the region's economic growth and rising disposable incomes have led to an increase in healthcare spending. This, in turn, drives the demand for medical devices as healthcare providers and individuals invest in advanced equipment and technology. Furthermore, advancements in technology and innovation have made medical devices more accessible and affordable, further fueling market growth. In conclusion, the Medical Devices market in APAC is experiencing significant growth and development driven by factors such as customer preferences, local special circumstances, and underlying macroeconomic factors. The region's diverse healthcare needs, government policies, and economic growth are shaping the market trends and driving the demand for medical devices in APAC.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)